Alkermes plc (ALKS) Stock Overview
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic
✓ Sourced directly from Yahoo Finance · Checked for accuracy at every rebuild · Snapshot: 6 September 2026
About Alkermes plc
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally. The company has a portfolio of proprietary…
Source: Yahoo Finance
Sector & Industry
Alkermes plc operates in the Healthcare sector, within the Drug Manufacturers - Specialty & Generic industry group. It is listed on the NASDAQ exchange.
Alkermes plc at a Glance
| Company | Alkermes plc |
| Ticker | ALKS |
| Exchange | NASDAQ |
| Currency | USD |
| Price | $46.10 |
| Market cap | $7.73B |
| P/E ratio (trailing) | 121.32 |
| EPS (trailing) | $0.38 |
| 52-week high | $55.67 |
| 52-week low | $25.17 |
| Dividend yield | — |
| Ex-dividend date | — |
| Beta | 0.26 |
| Return on equity (ROE) | 3.85% |
| Debt-to-equity | 86.95% |
| Average volume | 1.92M |
| Shares outstanding | 167.76M |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Employees | 2,050 |
| Country | Ireland |
Investing Essentials
As an Amazon Associate we earn from qualifying purchases. Links below are affiliate links.
Evaluating pharma pipelines, devices and healthcare economics.
Check Price →Peter Lynch on how everyday investors can spot winners before the professionals do.
Check Price →Benjamin Graham's classic on value investing — the book Warren Buffett calls the best ever written on the subject.
Check Price →Frequently Asked Questions
- What is Alkermes plc's current P/E ratio?
- Alkermes plc (ALKS) has a trailing P/E ratio of 121.32 as of our 6 September 2026 data snapshot. Learn what the P/E ratio means →
- What is Alkermes plc's market capitalisation?
- Alkermes plc's market cap is $7.73B based on our latest snapshot. See how it ranks by market cap →
- What is ALKS's 52-week range?
- Over the past 52 weeks, ALKS has traded between $25.17 and $55.67. What does the 52-week range mean? →
- How volatile is Alkermes plc compared to the market?
- Alkermes plc has a beta of 0.26, meaning it has historically moved less than the broader market. What does beta measure? →
- Does Alkermes plc pay a dividend?
- Alkermes plc does not currently pay a dividend according to our latest data.
- What exchange is ALKS listed on?
- ALKS is listed on the NASDAQ. Browse all NASDAQ-listed stocks →
- What sector is Alkermes plc in?
- Alkermes plc is classified in the Healthcare sector. Compare with Healthcare peers →
Prefer raw numbers at a glance? Browse our size and reference charts for quick lookups.
Many readers keep a stock investing journal to log positions and theses alongside pages like this one, and a dedicated financial calculator to hand for quick valuation maths.
Recommended Reading & Tools
Philip Fisher on what makes a business worth owning for the long term.
Check Price →Morgan Housel's short lessons on behaviour, luck and long-term wealth.
Check Price →Burton Malkiel's evidence-based guide to markets, indexing and long-term strategy.
Check Price →